Published in Am J Med on February 01, 1975
Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol (1979) 1.82
Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis (1975) 1.67
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome. Am J Pathol (1979) 1.39
Aortic incompetence in systemic lupus erythematosus. Br Med J (1976) 1.39
Pericardial heart disease: its morphologic features and its causes. Proc (Bayl Univ Med Cent) (2005) 1.39
Corticosteroids: do they damage the cardiovascular system? Postgrad Med J (1994) 1.32
Pericardial effusion and mitral valve involvement in systemic lupus erythematosus. Echocardiographic study. Ann Rheum Dis (1977) 1.28
Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis (2000) 1.15
The treatment of lupus nephritis by methyl prednisolone pulse therapy. Postgrad Med J (1978) 1.07
Why do patients with lupus nephritis die? Br Med J (Clin Res Ed) (1985) 1.06
Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis (1992) 1.06
Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev (2008) 1.02
Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis. Br Heart J (1979) 1.00
Valve replacement for severe tricuspid regurgitation caused by Libman-Sacks endocarditis. Br Heart J (1982) 0.98
Risk factors in cardiovascular disease in systemic lupus erythematosus. Curr Cardiol Rev (2013) 0.95
Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis (1977) 0.92
Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol (2014) 0.91
Transfer of renovascular hypertension and coronary heart disease by lymphoid cells from SLE-prone mice. Am J Pathol (1984) 0.91
Peripheral vascular disease in patients with systemic lupus erythematosus. Ann Rheum Dis (1992) 0.87
Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol (2010) 0.85
Double-valve Libman-Sacks endocarditis causing ventricular fibrillation cardiac arrest. Tex Heart Inst J (2011) 0.85
Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Fail Clin (2014) 0.84
Corticosteroid treatment, serum lipids and coronary artery disease. Postgrad Med J (1980) 0.83
Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv (2008) 0.82
Mitral regurgitation due to lupus endocarditis treated with valve replacement. Can Med Assoc J (1983) 0.82
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus. Semin Immunopathol (2014) 0.80
Libman-Sacks Endocarditis: Detection, Characterization, and Clinical Correlates by Three-Dimensional Transesophageal Echocardiography. J Am Soc Echocardiogr (2015) 0.80
Imaging assessment of cardiovascular disease in systemic lupus erythematosus. Clin Dev Immunol (2011) 0.80
Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.79
Risk factors for coronary heart disease in connective tissue diseases. Ther Adv Musculoskelet Dis (2010) 0.79
Neoplasms involving the heart, their simulators, and adverse consequences of their therapy. Proc (Bayl Univ Med Cent) (2001) 0.79
Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study. Arthritis Care Res (Hoboken) (2013) 0.78
Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus. Int J Cardiovasc Imaging (2014) 0.78
Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus. Ann Rheum Dis (1989) 0.77
Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Clin Rheumatol (2011) 0.77
Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus. Clin Rheumatol (1997) 0.77
Cardiovascular co-morbidity in patients with rheumatic diseases. Arthritis Res Ther (2011) 0.77
Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis. Rheumatology (Oxford) (2015) 0.77
Acute hemorrhagic myocarditis in systemic lupus erythematosus. Heart Vessels (1992) 0.76
Systemic and Central Nervous System Vasculitides. Curr Treat Options Neurol (2000) 0.76
[Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?]. Z Rheumatol (2005) 0.76
The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis. Rheumatol Int (2012) 0.76
Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction. Lipids Health Dis (2016) 0.75
Coronary artery bypass grafting in patients with systemic lupus erythematosus. Report of 2 cases. Tex Heart Inst J (1995) 0.75
Cardiovascular Complications of Collagen Vascular Disease. Curr Treat Options Cardiovasc Med (2002) 0.75
William Clifford Roberts, MD: an interview by W. Bruce Fye, MD. Proc (Bayl Univ Med Cent) (2007) 0.75
The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology. Ther Adv Musculoskelet Dis (2010) 0.75
Heart disease in systemic lupus erythematosus: diagnosis and management. Tex Heart Inst J (1985) 0.75
Systemic lupus erythematosus for general practitioners: a literature review. J Family Community Med (1994) 0.75
Immunological aspects of atheroma: a review. J R Soc Med (1979) 0.75
SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Res Ther (2003) 0.75
Coronary artery disease is a significant cause of morbidity and premature death in patients with systemic lupus erythematosus. Reumatologia (2015) 0.75
Long-term cardiac changes in patients with systemic lupus erythematosus. BMC Res Notes (2013) 0.75
Severe Bioprosthetic Mitral Valve Stenosis and Heart Failure in a Young Woman with Systemic Lupus Erythematosus. Case Rep Cardiol (2016) 0.75
Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome. Case Rep Transplant (2013) 0.75
Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease. Dis Model Mech (2017) 0.75
A 37-year-old man with primary antiphospholipid syndrome presenting with respiratory distress and worsening toe ischemia. Arthritis Care Res (Hoboken) (2016) 0.75
[Cardiovascular monitoring of patients with systemic lupus erythematosus]. Z Rheumatol (2005) 0.75
Assessment of vascular function in systemic onset juvenile idiopathic arthritis. Clin Rheumatol (2016) 0.75
Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int (2005) 0.75
Diastolic impairment in asymptomatic systemic lupus erythematosus patients. Clin Rheumatol (1997) 0.75
Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA (1996) 7.03
Quadricuspid semilunar valve. Am J Cardiol (1973) 5.07
Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med (1976) 4.85
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med (1982) 4.70
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation (1978) 4.45
Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med (1977) 4.34
Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest (1977) 4.21
Primary and secondary neoplasms of the heart. Am J Cardiol (1997) 3.79
The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol (1970) 3.69
Major anomalies of coronary arterial origin seen in adulthood. Am Heart J (1986) 3.57
The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med (1977) 3.50
Sudden death in young athletes. Circulation (1980) 3.05
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Solitary coronary ostium in the aorta in the absence of other major congenital cardiovascular anomalies. J Am Coll Cardiol (1993) 2.91
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68
Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation (1976) 2.58
Acute myocardial infarction and angiographically normal coronary arteries. An unproven combination. Circulation (1976) 2.56
Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation (1991) 2.52
Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation (1972) 2.49
The autopsy: its decline and a suggestion for its revival. N Engl J Med (1978) 2.49
Coronary artery embolism and myocardial infarction. Ann Intern Med (1978) 2.43
Iron in the heart. Etiology and clinical significance. Am J Med (1971) 2.40
Aortic dissection: anatomy, consequences, and causes. Am Heart J (1981) 2.37
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol (1968) 2.23
Getting cardiologists interested in lipids. Am J Cardiol (1993) 2.20
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Anomalous origin of either the right or left main coronary artery from the aorta with subsequent coursing between aorta and pulmonary trunk: analysis of 32 necropsy cases. Am J Cardiol (1988) 2.09
The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol (1968) 2.07
Unruptured sinus of Valsalva aneurysm. Am J Cardiol (1975) 2.04
Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty. Evidence from correlative angiographic-histomorphometric studies of atherosclerotic arteries in rabbits. Circulation (1994) 2.03
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med (1979) 1.96
Right-sided valvular infective endocarditis. A clinicopathologic study of twelve necropsy patients. Am J Med (1972) 1.95
The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation (1972) 1.93
Structural features of cardiac myxomas. Histology, histochemistry, and electron microscopy. Hum Pathol (1973) 1.90
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Atrial myxomas: a fifty year review. Am Heart J (1979) 1.83
Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia. Hum Pathol (1975) 1.80
Angiosarcoma of the heart. Am J Cardiol (1968) 1.79
Causes of early postoperative death following cardiac valve replacement. Clinico-pathologic correlations in 64 patients studied at necropsy. J Thorac Cardiovasc Surg (1967) 1.78
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer (1982) 1.77
The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. Am J Med (1972) 1.77
The structure of the aortic valve in clinically isolated aortic stenosis: an autopsy study of 162 patients over 15 years of age. Circulation (1970) 1.77
Clinical, electrocardiographic and morphologic features of massive fatty deposits ("lipomatous hypertrophy") in the atrial septum. J Am Coll Cardiol (1993) 1.77
Mitral valvular disease. A clinicopathologic survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med (1972) 1.76
The underused miracle drugs: the statin drugs are to atherosclerosis what penicillin was to infectious disease. Am J Cardiol (1996) 1.76
"Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol (1978) 1.76
Origin of the right coronary artery from the left sinus of valsalva and its functional consequences: analysis of 10 necropsy patients. Am J Cardiol (1982) 1.73
Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology (1994) 1.72
Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation (1976) 1.71
Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med (1979) 1.71
The heart in acute leukemia. A study of 420 autopsy cases. Am J Cardiol (1968) 1.69
Left main coronary artery originating from the right sinus of Valsalva and coursing between the aorta and pulmonary trunk. J Am Coll Cardiol (1986) 1.68
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation (1981) 1.66
Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients. Am J Cardiol (1970) 1.66
Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of coronary care units. Am J Cardiol (1989) 1.65
Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation (1982) 1.64
Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol (1979) 1.63
Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. J Clin Invest (1977) 1.61
Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation (1977) 1.60
The senile cardiac calcification syndrome. Am J Cardiol (1986) 1.60
The rule of 5 and the rule of 7 in lipid-lowering by statin drugs. Am J Cardiol (1997) 1.59
Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol (1975) 1.59
Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation (1973) 1.59
Papillary muscle rupture in fatal acute myocardial infarction: a potentially treatable form of cardiogenic shock. Ann Intern Med (1979) 1.58
Pseudoaneurysm of the left ventricle. An unusual sequel of myocardial infarction and rupture of the heart. Am J Med (1967) 1.57
Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56
Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. Am J Cardiol (1979) 1.55
Coronary arteries in fatal acute myocardial infarction. Circulation (1972) 1.54
Combined thoracic aortic dissection and abdominal aortic fusiform aneurysm. Ann Thorac Surg (1991) 1.53
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am J Cardiol (1973) 1.52
Mumps of the heart. Clinical and pathologic features. Circulation (1965) 1.52
The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med (1967) 1.52
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol (1974) 1.51
Anomalous left ventricular band. An unemphasized cause of a precordial musical murmur. Am J Cardiol (1969) 1.48
Living with a congenitally bicuspid aortic valve. Am J Cardiol (1989) 1.48
Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol (1983) 1.48
Obstruction to left ventricular outflow. Current concepts of management and operative treatment. Ann Intern Med (1968) 1.47
Lipid-lowering therapy after an atherosclerotic event. Am J Cardiol (1989) 1.46
Pathologic anatomy of cardiac valve replacement: a study of 224 necropsy patients. Prog Cardiovasc Dis (1973) 1.46
Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet (1970) 1.46
Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol (1984) 1.45
The carcinoid endocardial plaque; an ultrastructural study. Hum Pathol (1976) 1.45
Morphologic features of the normal and abnormal mitral valve. Am J Cardiol (1983) 1.44
An agent with lipid-lowering, antihypertensive, positive inotropic, negative chronotropic, vasodilating, diuretic, anorexigenic, weight-reducing, cathartic, hypoglycemic, tranquilizing, hypnotic and antidepressive qualities. Am J Cardiol (1984) 1.44
Coronary ostial dimple (in the posterior aortic sinus) in the absence of other coronary arterial abnormalities. Am J Cardiol (1993) 1.44
Calcific pulmonic stenosis. Circulation (1968) 1.43
Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis (1981) 1.42
Comparison of late degenerative changes in porcine bioprostheses in the mitral and aortic valve position in the same patient. Am J Cardiol (1983) 1.42
Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med (1981) 1.42
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation (1979) 1.41